Here, we identified a unique type of hepatic DUOX2+ACE2+ small cholangiocytes as the pathogenic target of PBC, because these cells express high levels of pIgR, and significantly elevated levels of serum anti-pIgR autoantibodies exist in PBC patients (Fig. 6). The gene discussed is ACE2; the disease is primary biliary cholangitis.